protein
| dsDNA-activated protein kinase |
|
pp60c-src and 50-kDa phosphoprotein |
|
myogenic differentiation 1, MYOD1 |
|
androgen receptor, AR |
|
casein kinase II, CKII |
|
calmodulin |
|
51 kDa FKBP, FKBP51 |
|
Ah receptor-interacting protein AIP |
|
52 kDa FK506-binding protein, FKBP52 |
|
homeodomain-only protein, HOP |
|
FKBP51/54 |
|
cell division cycle 37 homolog (S. cerevisiae), CDC37 |
|
proto-oncogene MTG8 (ETO/CDR) |
|
phosphoprotein phosphatase 5, PP5 |
|
tetratricopeptide repeat protein 1, TPR1 |
|
glucocorticosteroid receptor, GR |
|
death-associated protein 3, DAP3 |
|
glutamyl-prolyl-tRNA synthetase, EPRS |
|
Serine/threonine kinase Akt/PKB |
|
HBV X-associated protein 2, XAP2 |
|
carboxyl terminus of Hsc70-interacting protein, CHIP ) |
|
protooncogene Pim-1 |
|
apolipoprotein B48, apoB48 |
|
protein kinase RNA-activated, PKR |
|
G alpha(12) |
|
extracellular signal-regulated kinase 1, ERK1 and extracellular signal-regulated kinase 1, ERK2 |
|
phosphatidylinositide-3-OH kinase (PI3K) and 3-phosphoinositide-dependent protein kinase-1, PDK1 |
|
FKBP59, small acidic protein p23, Hsp-interacting and Hsp40 |
|
IKKalpha, IKKbeta and NEMO |
|
estrogen receptor, ER |
|
endothelial nitric oxide synthase, eNOS |
|
Cyclophilin 40 (CyP40) |
|
asialoglycoprotein, ASGPR |
|
TP53 |
|
IRE1alpha and PERK |
|
EGFRvIII |
|
peroxisome proliferator-activated receptor alpha, PPARalpha |
|
serine/threonine-protein kinase LKB1 |
|
activator of Hsp90 ATPase, Aha1 |
|
Tom70 |
|
signal transducer and activator of transcription 3, STAT3 |
|
telomerase reverse transcriptase, TERT |
|
activator of Hsp90 ATPase, Aha1 and high copy Hsp90 suppressor, Hch1 |
|
C. jejuni surface lipoprotein JlpA |
|
Heat shock factor 1, HSF1 |
|
Connexin 43, Cx43 |
|
matrix metalloproteinase 2, MMP2 |
|
ubiquitin fusion degradation protein 2, UFD2a and CHIP |
|
CDK11p46 |
|
protein phosphatase 5, Ppp5 |
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian), ERBB2 |
|
VEGF receptor 2 VEGFR2 |
|
interleukin-1 receptor-associated kinase 1, IRAK1 |
|
WAF-1/CIP1 stabilizing protein 39, WISp39 and cyclin-dependent kinase inhibitor 1A (p21, Cip1), p21 |
|
Neural Wiskott-Aldrich syndrome protein, N-WASP |
|
Hsp90-associating relative of Cdc37, HARC |
|
small serine/threonine kinase, SSTK |
|
Shepherdin |
|
histone deacetylase 6, HDAC6 |
|
Sp1 transcription factor, SP1 |
|
ribosomal protein S3, rpS3 |
|
Checkpoint kinase 1, Chk1 |
|
hypoxia-responsive pro-apoptotic protein, HGTD-P |
|
Ron(M1254T) |
|
GC-receptor, GCR |
|
Breast cancer metastasis suppressor 1, BRMS1 |
|
receptor-interacting protein 1, RIP1 and triad domain-containing protein 3, Triad3A |
|
orphan nuclear receptor small heterodimer partner, SHP |
|
N-myc downstream regulated 1, NDRG1 |
|
Death-associated protein kinase, DAPK |
|
vascular endothelial growth factor receptor 3, VEGFR3 |
|
TTC4 is a nucleoplasmic protein which interacts with HSP90AA1 and HSPA4, and also with the replication protein CDC6 |
|
RAF1, HSF1, CDC37, and MAP2K1 interacted with both HSP90AA1 and HSP90AB1, and the relative patterns of these interactions were not affected by heat shock 4) |
|
TPR (tetratricopeptide repeat)-containing protein associated with Hsp (heat-shock protein) 90], Tah1 |
|
TbetaRI and TbetaRII |
|
USP50 may act through a HSP90AA1-dependent mechanism to counteract CDC25B mitotic inducing activity and prevent WEE1 degradation |
|
TELO2-TTI1-TTI2 complex is a PIKK-specific cochaperone for HSP90AA1 |
|
LATS1 and LATS2 are novel HSP90AA1 clients and HSP90AA1 inhibitors can disrupt the LATS tumor suppressor pathway in cancer cells |
|
HSP90AA1 interacts predominantly with the cytosolic, inactive pool of PI4KB, shielding it from proteolytic degradation but also sequestering it to the cytosol until an extracellular stimulus triggers its translocation to the Golgi or plasma membrane and subsequent activation |
|
interacts and protects GABARAPL1 from its degradation by the proteasome |
|
HSP90AA1 plays a critical role in the regulation of HCV RNA polymerase phosphorylation via the PDK1-PKN2 signaling pathway |
|
HECTD1 is a substrates of HSP90AA1 |
|
involved in the regulation of OGT and O-GlcNAc modification and HSP90AA1 inhibitors might be used to modulate O-GlcNAc modification |
|
SUGT1, a cochaperone for HSP90AA1, 1s a novel PLK1 substrate during mitosis |
|
FKBP6 is a cochaperone that interacts with HSP90AA1 |
|
TCF12 expression is required for secreted HSP90AA1 to enhance colorectal cancer cell spreading |
|
HSP90AA1 interacts and stabilizes KDM4B protein |
|
similar to other atypical Rho GTPases, RHOBTB2 was found to have retained the capacity to bind GTP, modulated by the HSP90AA1 ATPase cycle |
|
HSP90AA1 and HSP90AB1, and not HSP90B1-GRP94 or TRAP1, are responsible for maintaining proper cellular levels of ARNTL protein (r |
|
importance of CUL5 in multiple aspects of the cellular response to HSP90AA1 inhibition |
|
supports tumor growth and angiogenesis through PRKD2 protein stabilization |
|
in response to cellular proliferation and DNA damage, proteasome and HSP90AA1-mediated regulation of POLB and XRCC1 alters the DNA repair complex architecture |
|
interactions of AICDA with EEF1A1 and heat-shock protein 90 kD (HSP90AA1) are inversely correlated |
|
HSP90AA1 and CDC37 cochaperone complex-mediated protein folding is thus an important part of the RIPK3 activation process during necroptosis. |
|
FLCN is an HSP90AA1 client protein and its binding partners FNIP1/FNIP2 function as co-chaperones |
|
FKBP8 binding to HSP90AA1 did not substantially influence its ATPase activity |
|
SUGT1-HSP90AA1 complex contributes to the E3 ligase activity of the CUL4A complex that is necessary for CENPA ubiquitylation and CENPA deposition at the centromere |
|
UNC45B is a unique chaperone in which the TPR domain recruits HSP90AA1 |
|
because methylation represses ESR1 activity, the observed complex formation between SMYD2 and HSP90AA1/PTGES3 may contribute to ESR1 regulation |
|
STIP1 is a co-chaperone of HSPA4 and HSP90AA1 that regulates a number of cell biology processes via interactions with cellular proteins |
|
HSP90AA1 interacted with HMGCR, the rate& |
|
8209;limiting enzyme of mevalonate pathway, and regulated its protein expression level by inhibiting protein degradation |